奋进“十五五” 阔步向未来｜庆安 科技赋能激发医药产业新活力

Group 1 - The pharmaceutical manufacturing industry in Qing'an County is focusing on technological innovation as a core driver for development, aiming for breakthroughs in formulation, intelligent upgrades, and cross-industry integration [1] - Heilongjiang Aolida Naide Pharmaceutical has invested nearly 50 million yuan in consistency evaluation for generic drugs, resulting in five products approved for market, including a unique product with a market share of 70% to 80% [1] - The company is also expanding its product matrix with new approvals expected this year, including oral solutions and small-volume injectables [1] Group 2 - Heilongjiang Zhonggui Pharmaceutical has established a high-level innovation platform recognized by the provincial government, with an annual investment of about 20 million yuan in technology innovation and new product development [2] - The company has received awards for its industrialization of oral solutions and has secured funding for major technological achievements, promoting a cycle of research, transformation, and industrialization [2] - Heilongjiang Ruige Pharmaceutical is undergoing a digital and intelligent transformation in traditional Chinese medicine manufacturing, enhancing production stability and increasing extraction rates by at least 10% [2] Group 3 - Heilongjiang Kelong Pharmaceutical is diversifying into the health beverage market, leveraging its pharmaceutical-grade production environment to create products from local resources, aligning with consumer trends and seeking new growth opportunities [3] - By 2026, Qing'an County aims to leverage technological innovation to drive high-quality development in key industries, contributing to the revitalization of Northeast China and the establishment of a modernized Heilongjiang [3]